BofA/Merrill Lynch Reinstated Cree (CREE) at Underperform
Tweet
Share
E-mailGet Alerts CREE Hot Sheet
Price: $79.12 --0%
Rating Summary:
9 Buy, 22 Hold, 8 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
9 Buy, 22 Hold, 8 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
BofA/Merrill Lynch reinstated coverage on Cree (NASDAQ: CREE) with a Underperform. PT $17.00.
For an analyst ratings summary and ratings history on Cree click here. For more ratings news on Cree click here.
Shares of Cree closed at $25.67 yesterday.
For an analyst ratings summary and ratings history on Cree click here. For more ratings news on Cree click here.
Shares of Cree closed at $25.67 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Starts Definium Therapeutics Inc (DFTX) at Buy
- BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
- Craig-Hallum Starts Horizon Quantum (HQ) at Buy
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
